Articles by Charlotte Schubert

Charlotte Schubert is a GeekWire reporter and science journalist with a focus on biotech, healthcare, and life sciences. She is a Seattle native, former editor at Nature Medicine, and recovering lab rat. Follow her on Twitter at @schubertcm or reach her at charlotte@geekwire.com.

Startup detects COVID-19 using spit, light, and a computer built to analyze patterns

Dr. Anthony Fauci stops in Seattle for Fred Hutch Q&A, throws first pitch at Mariners game
Prime healthcare: How Amazon’s $3.9B One Medical deal could boost its subscription program
Can Amazon change healthcare? Experts sound off on tech giant’s $3.9B deal to buy One Medical

Latest from Charlotte Schubert

Seattle startup aiming to detect, treat Alzheimer’s and Parkinson’s disease raises cash

by Charlotte Schubert on August 22, 2022August 22, 2022 at 8:10 am

The news: University of Washington spinout AltPep recently raised $44.4 million, according to a regulatory filing. The company declined to discuss the filing, but founder and CEO Valerie Daggett spoke… Read More

News Brief

Nortis, a Seattle-based startup developing ‘organ-on-a-chip’ tech, raises cash

by Charlotte Schubert on August 19, 2022August 19, 2022 at 3:59 pm

Nortis, a Seattle-area startup founded in 2011 that markets “organ-on-a-chip” technology, has raised $6 million, according to an SEC filing. The company’s microfluidic chips foster the growth of human cells… Read More

Startup detects COVID-19 using spit, light, and a computer built to analyze patterns

by Charlotte Schubert on August 18, 2022August 18, 2022 at 12:23 pm

A Seattle-area startup called Pattern Computer is developing a rapid COVID-19 test based on patterns in light from spit, one of several projects moving ahead from the 7-year-old company that designed its… Read More

Seattle-area company that aims to treat disease with radio frequency energy files for IPO

by Charlotte Schubert on August 17, 2022August 17, 2022 at 5:09 pm

EMulate Therapeutics, a 20-year-old Bellevue, Wash.-based company developing radio frequency energy technology to treat a range of diseases, filed to go public Tuesday. The 7-person company, previously known as Nativis,… Read More

Institute for Protein Design spinout Monod Bio raises $25M for molecular biosensors

by Charlotte Schubert on August 15, 2022August 15, 2022 at 8:33 am

The news: Monod Bio raised $25 million to develop molecular biosensors that light up when they bind their target. The sensors can be designed to detect molecules linked to disease and… Read More

Tech Moves: Nuance engineering director lands at Ozette; AWS exec will depart; and more

by Charlotte Schubert on August 12, 2022August 12, 2022 at 2:04 pm

— Amarjit Kaur Sandhu joined Fred Hutchinson Cancer Center spinout Ozette Technologies as vice president of engineering. She previously was director of software engineering at Nuance Communications, which acquired Seattle… Read More

Seattle startup HDT Bio lands $1.8M U.S. Army grant to develop nasal spray against viruses

by Charlotte Schubert on August 11, 2022August 11, 2022 at 7:56 am

Seattle startup HDT Bio will develop a nasal spray designed to counteract a wide range of respiratory viruses with a nearly $1.8 million grant from the U.S. Army. “We hope… Read More

Publicly traded biotech company Absci lays off employees, citing ‘macro-economic conditions’

by Charlotte Schubert on August 10, 2022August 10, 2022 at 10:35 am

Vancouver, Wash.-based drug design and development company Absci laid off employees Tuesday, a little more than a year after going public. “The macro-economic conditions of the last few months prompted… Read More

Fred Hutch spinout lands $10M for precision test to guide cancer treatment, develop drugs

by Charlotte Schubert on August 10, 2022August 10, 2022 at 4:35 pm

Seattle startup SEngine Precision Medicine has raised $10 million to propel drug discovery and development and advance its test that tailors drugs to cancer patients. SEngine cultures patient cancer cells… Read More

Video

Dr. Anthony Fauci stops in Seattle for Fred Hutch Q&A, throws first pitch at Mariners game

by Charlotte Schubert on August 9, 2022August 16, 2022 at 12:25 pm

Anthony Fauci, President Biden’s chief medical advisor and a leader of the country’s COVID-19 response, made a pit stop in Seattle for a fireside chat at Fred Hutchinson Cancer Center… Read More

Tech Moves: Rover appoints CFO; Smartsheet adds board member; Nautilus Biotechnology hires execs

by Charlotte Schubert on August 8, 2022August 12, 2022 at 11:26 am

— Pet sitting marketplace Rover appointed Charlie Wickers to chief financial officer. Wickers joined Rover in 2017 and most recently served as vice president of finance. He replaces Tracy Knox,… Read More

Tech Moves: Accolade hires security chief; Blue Origin comms leader departs; Redfin names industry relations director; and more

by Charlotte Schubert on August 5, 2022August 5, 2022 at 11:54 am

— Kelli Burns joined Seattle-based healthcare company Accolade as its new chief information security officer. Burns comes from Bellevue, Wash.-based financial services company Symetra, where she held the same role. Burns… Read More

Seattle approves permanent 15% fee cap on food delivery companies, with key compromise

by Charlotte Schubert on August 2, 2022August 2, 2022 at 4:39 pm

The Seattle City Council voted Tuesday to permanently implement a 15% cap on the fees that services such as Uber Eats, DoorDash, Grubhub, and others charge restaurants for food delivery. The… Read More

Prime healthcare: How Amazon’s $3.9B One Medical deal could boost its subscription program

by Charlotte Schubert on August 1, 2022August 1, 2022 at 11:04 am

Will consumers order up healthcare through Amazon Prime as easily as they stream The Boys or buy an Echo speaker? That’s one question raised by Amazon’s planned $3.9 billion acquisition… Read More

News Brief

Seagen reports $498M in Q2 revenue, stays silent on reported sale to Merck

by Charlotte Schubert on July 28, 2022July 28, 2022 at 5:20 pm

Seagen reported second quarter revenue of $498 million, up 28%, beating analyst expectations. The company also recently reported “positive” early data from a trial testing its drug Padcev in combination… Read More

Seattle biotech startup Ozette lands $26M from Microsoft, Madrona, others to analyze immune cells

by Charlotte Schubert on July 28, 2022July 28, 2022 at 2:59 pm

The news: Single cell analysis startup Ozette Technologies, with deep roots in the Seattle academic and startup community, has raised $26 million. The company’s tools enable its academic and biopharma… Read More

Biotech startup developing therapies that match molecules in human milk withdraws IPO filing

by Charlotte Schubert on July 26, 2022July 26, 2022 at 1:54 pm

A quiet Seattle biotech company, Intrinsic Medicine, filed to go public in April but withdrew its plans yesterday, according to a regulatory filing. Intrinsic Medicine is developing sugar-based molecules matching… Read More

Tech Moves: Amazon promotes two execs to SVP; Providence exec named Teladoc COO; and more

by Charlotte Schubert & Todd Bishop on July 26, 2022July 27, 2022 at 1:09 pm

— Amazon has promoted two executives to senior vice president: James Hamilton, a distinguished engineer at the company; and Drew Herdener, who leads worldwide communications. Both were previously vice presidents… Read More

News Brief

Articles by Charlotte Schubert

Top Stories from Charlotte Schubert

Startup detects COVID-19 using spit, light, and a computer built to analyze patterns

Latest from Charlotte Schubert

Seattle startup aiming to detect, treat Alzheimer’s and Parkinson’s disease raises cash

Nortis, a Seattle-based startup developing ‘organ-on-a-chip’ tech, raises cash

Startup detects COVID-19 using spit, light, and a computer built to analyze patterns

Seattle-area company that aims to treat disease with radio frequency energy files for IPO

Institute for Protein Design spinout Monod Bio raises $25M for molecular biosensors

Tech Moves: Nuance engineering director lands at Ozette; AWS exec will depart; and more

Seattle startup HDT Bio lands $1.8M U.S. Army grant to develop nasal spray against viruses

Publicly traded biotech company Absci lays off employees, citing ‘macro-economic conditions’

Fred Hutch spinout lands $10M for precision test to guide cancer treatment, develop drugs

Dr. Anthony Fauci stops in Seattle for Fred Hutch Q&A, throws first pitch at Mariners game

Tech Moves: Rover appoints CFO; Smartsheet adds board member; Nautilus Biotechnology hires execs

Tech Moves: Accolade hires security chief; Blue Origin comms leader departs; Redfin names industry relations director; and more

Seattle approves permanent 15% fee cap on food delivery companies, with key compromise

Prime healthcare: How Amazon’s $3.9B One Medical deal could boost its subscription program

Seagen reports $498M in Q2 revenue, stays silent on reported sale to Merck

Seattle biotech startup Ozette lands $26M from Microsoft, Madrona, others to analyze immune cells

Biotech startup developing therapies that match molecules in human milk withdraws IPO filing

Tech Moves: Amazon promotes two execs to SVP; Providence exec named Teladoc COO; and more

Seagen releases data on combination therapy with Merck drug amid acquisition reports

Frazier Healthcare Partners to bring Dutch biotech company public in SPAC deal

Can Amazon change healthcare? Experts sound off on tech giant’s $3.9B deal to buy One Medical

‘Keep Amazon out’: Protestors demand tech giant pull permit for potential warehouse in Seattle

Silverback Therapeutics to merge with San Diego biotech company developing EpiPen alternative

A startup spinout machine; Amazon teams with Fred Hutch; and more life sciences news

Tech Moves: Vimeo hires Seattle execs; Microsoft corporate VP retires; and more

Computer science lecturer sues Univ. of Wash. leaders over indigenous lands statement

Tech Moves: Twilio hires ex-Microsoft engineering leader as CTO; Nintendo adds exec; and more

Fred Hutch and Amazon collaborating on clinical trial to test vaccines against cancer

Spinning out science startups: UW’s Institute for Protein Design brings research beyond ivory tower

Tech Moves: Microsoft Teams leader lands at Lyft; General Fusion hires new CEO